2022 Multiple-country Monkeypox Outbreak and Its Importation Risk into China: an Assessment Based on the Risk Matrix Method.
Min Du,Shi Mo Zhang,Wei Jing Shang,Wen Xin Yan,Qiao Liu,Chen Yuan Qin,Min Liu,Jue Liu
DOI: https://doi.org/10.3967/bes2022.115
IF: 2.831
2022-01-01
Biomedical and Environmental Sciences
Abstract:Objective To analyze the 2022 multiple-country monkeypox outbreak and assess its importation risk into China. Methods Data was from United States Centers for Disease Control and Prevention. We described the global epidemic and calculated concentration index to measure economic-related inequality. Importation risk into China was evaluated and ranked by using risk matrix method and Borda count method, respectively. Results As of July 29, 2022, of 79 countries or territories, 39 (49.37%, 39/79), 17 (21.52%, 17/79), 6 (7.59%, 6/79), 12 (15.19%, 12/79), and 5 (6.33%, 5/79) country or territories identified cases < 10, 10-, 51-, 101-, and > 1,000. There were economic-related health disparities exist in the distribution of cases (the concentration index = 0.42, P = 0.027), and the inequality disadvantageous to the rich (pro-poor). There were 12 (15.38%, 12/78), 15 (19.23%, 15/78), 6 (7.69%, 6/78), and 45 (57.69%, 45/78) countries or territories with extremely high, high, moderate, and low importation risk. United States and France ranked first with the highest Borda points of 156, and counts of zero. Conclusion Of 78 countries or territories, the key attention need be paid to the United States and France, relatively. As the epidemic progresses, preparing prevention and control measures to further reduce importation risk was crucial.